BACKGROUND: The purpose of this study was to evaluate the efficacy and safety of pharmacomechanical thrombectomy performed by using a rotational thrombectomy device for the treatment of @entity1150 . METHODS: Between April 2012 and November 2014, 17 @entity1 with acute @entity1150 underwent pharmacomechanical thrombolysis. The thrombectomy device was used in a single-session technique for @entity1 with @entity1150 . After the procedure, the effect of thrombolysis was evaluated in 3 grades venographically. Grade I showed lysis of under 50%, and grade III showed complete lysis. RESULTS: Ten @entity1 (58.8%) had an iliofemoral @entity715 and 7 (41.2%) had a femoropopliteal @entity49 . At the end of the pharmacomechanical thrombectomy procedure, 12 @entity1 (70%) had complete (grade III) @entity715 resolution. Grade I and II lysis were noted in 2 (12%) and 3 (18%) @entity1 , respectively. Additionally, four (23.5%) required an additional lytic infusion as a result of residual thrombi. The overall grade III, II, and I @entity715 resolution rates, including the supplemental thrombolysis, were 82.2% (n = 14), 12% (n = 2), and 5.8% (n = 1), respectively. There was no mortality. CONCLUSION: Based on the present data, use of the Cleaner thrombectomy device may prove to be a safe and feasible single-session pharmacomechanical thrombectomy method for the treatment of acute @entity1150 . To prove the effectiveness of this type treatment, a more extensive large-scale studies are needed.

Pharmacomechanical Thrombectomy for Acute Symptomatic Lower Extremity XXXX .

@entity1150 :: ('MESH:D020246', 'Disease') :: ['deep vein thrombosis', 'lower-extremity deep vein thrombosis'] @entity1 :: ('9606', 'Species') :: ['patients'] @entity49 :: ('MESH:D019851', 'Disease') :: ['venous thrombosis'] @entity715 :: ('MESH:D013927', 'Disease') :: ['thrombus', 'thrombosis']
@entity1150 :: (MESH:D020246,Disease) :: ['Deep Venous Thrombosis']
